TCT-311 Everolimus- Versus Zotarolimus-Eluting Stent Following Percutaneous Coronary Chronic Total Occlusion Intervention
After multivariable adjustment, no significant difference was observed between the two groups in terms of the risk of primary outcome (Hazard ratio [HR] 1.03, 95% confidence interval [CI] 0.59-1.79, P = 0.930 for ZES compared with EES), as well as the risks of death (adjusted HR 0.96, 95% CI 0.43-2....
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2016-11, Vol.68 (18), p.B128-B128 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!